Syntracts | $5,300,000 | (Oct 24, 2025)
GradBridge | $20,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
RDS
France
- Strasbourg, Grand Est
- 30/09/2025
- Series A
- $16,412,468
RDS is a French Start-Up / MedTech based in Strasbourg, France.
We leverage best-in-class biosensor technologies, combined with the latest developments in digital and predictive medicine, and bring to life the next generation of Patient Monitoring Solutions.
Our main product, MultiSense®, offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond.
MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards.
RDS relies on a talented and international team with deep subject-matter-expertise and a proven track record in the Healthcare and Medical Device sector.
At RDS, we all share the same passion for bringing patient pathways to the next level.
- Industry Medical Equipment Manufacturing
- Website https://rdsdiag.com/en/
- LinkedIn https://www.linkedin.com/company/rds-rhythm-diagnostic-systems/
Related People
Elie LobelFounder
France -
Strasbourg, Grand Est
I have been working in the field of digital health and e-health for several years, with a specific focus on connected medical devices, hospital IT, and medical imaging. I have been working in the public and private sectors, including startups, and I am co-founder and CEO of RDS.
I have a scientific and a medical background, and I like to communicate to share my passion for technologies and innovations and how they can improve healthcare.
Thanks to my different positions, I gained significant management experience, including team management, P&L management, growth strategies and M&A. I have also been in charge of managing several very large projects, in France and in Europe.
My goals are "results oriented", with a strong focus on team involvement through empowerment and active listening. I like to unite and manage teams on ambitious projects and solutions, and create the conditions for transformation and collaborative innovation.
CipherOwl | $15,000,000 | (Oct 24, 2025)
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
Vermeer | $10,000,000 | (Oct 24, 2025)
GammaTime | $14,000,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Apriority Financial, Inc. | $2,300,000 | (Oct 24, 2025)
OneAM | $4,700,000 | (Oct 24, 2025)
🌱 Rightcharge | $2,131,920 | (Oct 24, 2025)
Tensormesh | $4,500,000 | (Oct 24, 2025)